APEX NEURO LTD

Company number 12711827 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£149,787

Balance sheet as at 2026-03-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2020-07-01
Employees
6 (2026 accounts · was 4 in 2025)
Registered office
C/O Cutts And Co Eden Point, Three Acres Lane, Cheadle Hulme, Cheadle, England, SK8 6RL
Postcode
SK8 6RL
Capital
100 GBP
Accounts category
Micro

Accounts

Last made up to
2026-03-31
Next due by
2027-12-31
Financial year end
31 March

Confirmation statement

Last statement dated
2026-02-14
Next due by
2027-02-28
View filing history →

Nature of business (SIC)

  • 71200 Technical testing and analysis
  • 86900 Other human health activities
  • 93199 Other sports activities

Officers 2 current

Subscribers only Director
Subscribers only Appointed 2022-02-03
Subscribers only Director
Appointed 2020-07-01

View all officers and resignations →

Data protection registration

Registered with the ICO as a data protection fee payer — ZC006830 (Tier 1), registered since 2025.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
apexneuro.co.uk
Phone
+447939697150

APEX NEURO | Leaders in neurorehabilitation, specialising in Multiple Sclerosis, Motor Neurone Disease / ALS and Functional Neurological Disorder | UK's most experienced Neufit practitioners, first UK clinic with Neubie Therapy

Among its peers

272

companies are registered at this postcode →

No.9 of the largest technical testing and analysis companies in Stockport →

Competitors Stockport

This company ranks 9 among technical testing and analysis in Stockport.

Full league table →

The class of 2020

32%

of the 532 companies in this sector incorporated in 2020 are still active today; 65% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →